Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Minority Interest: 2014-2015

Historic Minority Interest for Enanta Pharmaceuticals (ENTA) over the last 1 years, with Dec 2015 value amounting to $164,000.

  • Enanta Pharmaceuticals' Minority Interest was N/A to $164,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $164,000, marking a year-over-year change of. This contributed to the annual value of $163,000 for FY2015, which is 19.31% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Minority Interest of $164,000 as of Q4 2015, which was up 0.61% from $163,000 recorded in Q3 2015.
  • In the past 5 years, Enanta Pharmaceuticals' Minority Interest ranged from a high of $202,000 in Q3 2014 and a low of $163,000 during Q3 2015.
  • Over the past 2 years, Enanta Pharmaceuticals' median Minority Interest value was $174,500 (recorded in 2015), while the average stood at $178,500.
  • Data for Enanta Pharmaceuticals' Minority Interest shows a maximum YoY decreased of 19.31% (in 2015) over the last 5 years.
  • Quarterly analysis of 2 years shows Enanta Pharmaceuticals' Minority Interest stood at $202,000 in 2014, then decreased by 19.31% to $164,000 in 2015.
  • Its Minority Interest stands at $164,000 for Q4 2015, versus $163,000 for Q3 2015 and $185,000 for Q2 2015.